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in Chinese subjects with down syndrome
Winnie Ka Yan Mok, Wilfred Hing-Sang Wong, Gary Tsz Kin Mok, Yoyo Wing Yiu Chu, Frederick Ka Wing Ho,
Chun Bong Chow, Patrick Ip* and Brian Hon-Yin Chung*Abstract
Objectives: The objectives of the study were (1) to validate the Chinese version of Health Utilities Index (HUI-Ch);
(2) to examine the Health-related Quality of Life (HRQoL) of Chinese subjects with Down syndrome (DS); and (3) to
study the impact of chronic health conditions on HRQoL of Chinese with DS.
Methods: The multiple choice questionnaire for scoring Health Utilities Index Mark 2 (HUI2) and Health Utilities
Index Mark 3 (HUI3) was translated and validated. In addition to the HRQoL scores from HUI2 and HUI3, proxy-data
on socio-demographics, and 10 common chronic health conditions for people with DS were collected and analyzed.
Data analysis involves multiple imputation and multiple regression analysis to predict variations in HRQoL in relation to
different factors. Lastly, a gradient interval was constructed on the number of chronic health conditions in relation to
HRQoL.
Results: HUI-Ch was validated according to standard guidelines. People with DS were found to have a lower HRQoL as
compared to the general population, with the majority categorized as moderate or severe on the scale. Behavioral and
hearing problems on HUI2, and hearing problems on HUI3 were found to be statistically significant predictors of a
lower HRQoL score. A significant gradient relationship existed showing when the number of health problems
increased, the HRQoL scores decreased.
Conclusions: HUI-Ch is a valid instrument to assess HRQoL. It can have broad application in Chinese subjects with DS
including the study of the impact of different chronic health conditions on their quality of life. The quantifiable nature
of HUI-Ch will facilitate longitudinal study on the well-being of subjects with DS and evaluation of effectiveness
of intervention programs in the near future.
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Down syndrome (DS), also known as trisomy 21, is the
most common chromosome abnormality characterized
by having an extra copy of chromosome 21. Globally,
the incidence ranges from 1 in 650 to 1000, estimating
the total number of people with DS to be 6 million [1,2].
In Hong Kong, a similar incidence rate of 1 in 767 live
births was found [3].
Epidemiologic studies have identified people with DS
to have an increased risk of chronic health conditions* Correspondence: patricip@hku.hk; bhychung@hku.hk
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unless otherwise stated.including cardiac, endocrine, gastrointestinal, immuno-
logical, respiratory, musculoskeletal, as well as onco-
logical diseases [4-10]. It has been suggested that people
with DS has a unique aging profile, with premature on-
set and rapid progressing manifestation of age-related
conditions such as menopause, sensory impairments,
thyroid dysfunction, diabetes, sleep apnea, and Alzheimer’s
disease [11-20]. Their functional capability is limited due
to mental impairment, affecting their learning abil-
ities, verbal working memory, and receptive language
[21,22]. Behavior problems such as impaired social
development, impulsive behavior, poor judgment, and
short attention span are also commonly observed amongst
people with DS [1].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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dimensional concept reflecting life quality related to
physical, mental, emotional and social functioning. As
defined by the World Health Organization (WHO), the
HRQoL comprises of six domains: physical health, psy-
chological well-being, level of independence, social rela-
tionships, environment, and personal beliefs. In subjects
with DS, the diverse set of physical and development im-
pairments is likely to adversely impact their HRQoL. As
demonstrated by a study using the TNO-AZL Children’s
Quality of Life questionnaire, a significant deficit in
HRQoL was observed in a group of 8-year-old children
with DS as compared to a normative population [22].
Another study found that recurrent respiratory tract
infections had a large adverse impact on the HRQoL of
children with DS [23].
As the longevity of people with DS increased over the
years, the life expectancy was observed to be around
60 years of age [10,13,24-26]. Published studies evaluat-
ing HRQoL of people with DS were so far limited and
primarily focused on children, assessing only one disease
group, and of western population. The HRQoL of adults
with DS have not been well studied, and outcome mea-
sures may also be different in Chinese. Therefore, the
objectives of this study were: 1) to validate the Chinese
version of Health Utilities Index (HUI-Ch), 2) to deter-
mine the HRQoL of both adult and paediatric Chinese
subjects with DS, and 3) to study the relationship be-
tween chronic health conditions and HRQoL of Chinese
subjects with DS.
Methods
Two health-state classification systems, Health Utilities
Index Mark 2 (HUI2) and Health Utilities Index Mark 3
(HUI3) were used to measure HRQoL. These instruments
are non-disease specific index applicable to individuals
over the age of 5 and have been shown to be respon-
sive to various chronic diseases such as rheumatoid
arthritis [27], type 2 diabetes [28], and stroke [29].
HUI2 and HUI3 are 2 independent yet complementary
systems measuring HRQoL. Each of HUI2 and HUI3
includes a generic comprehensive health status classifi-
cation system and a generic HRQoL utility scoring sys-
tem. Outlines of the different attributes measured
between the two HUI system were included in the
Additional files.
The 15-multiple choice questionnaire allows scoring
subjects according to HUI2 and HUI3. HUI2 describes an
individual’s functional health status using 7 health attri-
butes (Sensation, Mobility, Emotion, Cognition, Self-Care,
Pain and Fertility) distinguished by 3–5 descriptive levels
(see Additional file 1: Table S1) while HUI3 describes
using 8 health single-attributes (Vision, Hearing, Speech,
Ambulation, Dexterity, Emotion, Cognition and Pain)distinguished by 5–6 descriptive levels (see Additional
file 2: Table S2). A multiplicative scoring algorithm using
the individual health attributes of HUI2 and HUI3 yield
the multi-attribute utility scores, which is the numerical
measurement for HRQoL. HRQoL score has an interval-
scale property with score of 0.00 being conventional dead
to 1.00 being in perfect health [30-35].
Translation and validation of HUI (traditional Chinese
version)
English-language HUI questionnaire obtained from Health
Utilities Inc. (HUInc) was translated into traditional
Chinese language (HUI-Ch) for adaptation and use in
Chinese population. The research team followed the
stringent translation and adaptation procedures of HUI
instrument in accordance to the guideline set out by
HUInc. This included forward translation by an academic
translator, followed by 2 backward translations by a
board-certified genetic counselor and a research assist-
ant independently. Discrepancies were identified, ana-
lyzed, and revised internally and reviewed by HUInc
personnel as well as experts in the field to ensure lin-
guistic equivalence between the original and translated
version. Acceptability testing on 5 healthy Chinese adults
was also conducted to ensure consistency between English
and Chinese version of HUI.
Chinese subjects with DS were recruited in collabor-
ation with the Hong Kong Down Syndrome Association
(HKDSA). Staff of HKDSA invited parents or caregivers
of people with DS to complete a questionnaire and a
proxy version of the Chinese translated version of HUI
at various activities hosted by HKDSA. Detailed explana-
tions were provided to participants and their families be-
fore they signed the consent. Verbal instructions were
provided to respondents on how to fill in the question-
naire and on the clarification of any unclear items. The
study aimed at recruiting as many subjects as possible
and the recruitment was carried out over the 6 months
period from Dec 2012 to May 2013. The participants did
not receive any incentives and none of them requested
to leave the study. Because of varying intellectual ability
of the people with DS, respondents were the parents or
caregivers, whom provided answers in lieu of the indi-
vidual with DS. An information sheet was provided to
each participant and his/her family to clearly inform
about the purpose and details of the survey and pro-
vide participant a contact phone number to reach our
research team. Consent form was signed by each par-
ticipant’s family member before he/she joined the study.
To protect participant’s privacy, a unique study num-
ber (instead of personal ID number) was assigned to
each participant and the data were all kept in a com-
puter with protected password locked in our Univer-
sity office.
Table 1 Characteristics of subjects with Down syndrome
n %
Age (in years)
5-18 30 28%
>18 79 72%
Gender
Male 61 56%
Female 48 44%
Race
Chinese 109 100%
Hong Kong Resident Status:
Permanent resident 108 99%
Singly- non-permanent resident 0 0%
Doubly- non-permanent resident 1 1%
Non-residence 0 0%
Primary Language spoken:
Cantonese 108 99%
Putonghua 1 1%
Proxy-relation:
Mother 97 89%
Father 6 6%
Sibling 4 4%
Others 2 2%
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Data on the HRQoL, DS subject’s demographics, and
chronic health conditions (as defined by local population-
based health survey [36]) were collected and used for ana-
lysis. Ten chronic health conditions more prevalent in DS
[5,8,22,37-39] were selected and categorized into 2 groups,
namely physical health problem and developmental-
behavioral problem. The five physical health problems
included cardiac diseases, endocrine problems, growth
problem, sleep disturbances, and chronic orthopedic bone/
joint problems. The five developmental-behavioral prob-
lems included behavior problems, speech problems, learn-
ing problems, hearing impairment/deafness, and vision
problems. Respondents were asked to report if the health
condition has been observed in the individual with DS.
Data analysis
HUI data were analyzed according to the manual provided
by HUInc. The tabulated HRQoL scores were then catego-
rized into 4 disability levels (none, mild, moderate, severe)
as proposed by the HUI developers. Such categorization
method has been validated as appropriate for assessing dis-
ability levels for comparison to general population [40].
The disability level descriptions are summarized in
Additional file 3: Table S3. Missing data were treated
using multiple imputations with 5 times imputations.
Unpaired t-tests were used to test the univariate rela-
tionship between HRQoL scores and demographics
and different chronic health conditions. Significant fac-
tors correlating to HRQoL scores were then put into
multiple linear regression models. R statistical software
version 3.0.1 was used for the analysis. A p-value with
2-tail < 0.05 was treated as significant. Exclusion cri-
teria included non-Chinese and those individuals with
DS under the age of 5.
This study received ethics approval from the Institu-
tional Review Board of the University of Hong Kong/
Hospital Authority Hong Kong West Cluster.
Results
Characteristics of study population
A total of 109 individuals with DS participated in this
study. As summarized in Table 1, 79 (72%) were adults
while 30 (28%) were aged 18 or below. Sixty-one (56%)
of participants were male. All were Chinese descendants;
with 99% of them being Hong Kong permanent resi-
dents using Cantonese as their primary language. As the
survey was proxy-assessed, we found that 89% of the re-
spondents were mothers of the subject with DS, 6% were
fathers, 4% were siblings, and 2% were other relatives.
Self-reported chronic health conditions
The self-reported chronic health conditions were catego-
rized into physical health and developmental-behavioralproblems. Physical health problems included 10 (9%)
cardiac disease, 24 (22%) endocrine problems, 27 (25%)
growth problems, 18 (17%) sleep disturbance issues, and
11 (10%) chronic orthopedic bone or joint problems.
Developmental-behavioral problems included 18 (17%)
behavioral problems, 58 (53%) speech problems, 55
(50%) learning problems, 21 (19%) hearing impairment
or deafness, and 50 (46%) vision problems.
HRQoL analysis
Categorization of HRQoL scores into disability level shown
in Figure 1 illustrated that the majority of Chinese people
with DS were in the ‘severe’ disability group. As shown in
Table 2, analysis using unpaired t-test and multiple regres-
sion for both HUI2 and HUI3 showed that demographic
factors (gender and age) and physical conditions did not
affect their HUI2 and HUI3 HRQoL scores.
Evaluating the impact of different factors on HUI2
HRQoL scores indicated that those having developmental-
behavioral conditions (problems in behavioral (p < 0.01),
speech (p = 0.01), learning (p = 0.04), hearing (p < 0.01),
and vision (p = 0.03)) had a significantly lower HUI2
HRQoL score. Among them, only behavior problems (p =
0.04) and hearing problems (p = 0.03) were found to be sig-
nificant indicators for a lower HRQoL score by multiple
regression. We found lower HUI3 scores among those
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Figure 1 HUI2 and HUI3 HRQoL scores in individuals with DS (n = 109). *HUI3 Reference Source: 2005 Canadian Community Health Survey,
which represents the HRQoL of 18,271 Canadians with no chronic conditions at all [41].
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lems in behavioral (p = 0.02), speech (p < 0.01), learning
(p = 0.01), hearing (p < 0.01), and vision (p < 0.01)) and
among those who had at least one physical conditions
(endocrine problems (p = 0.02)). Hearing problem (p = 0.03)Table 2 Chronic health conditions in HUI2/HUI3 scores
HUI2
Two-sample t-test Multiple re
Mean (SD) p p
Physical conditions
Endocrine problems 0.17 -
No 0.74 (0.15)
Yes 0.69 (0.15)
Developmental-behavioural conditions
Behavioural problems <0.01* 0.04*
No 0.75 (0.14)
Yes 0.64 (0.16)
Speech problems 0.01* 0.47
No 0.77 (0.15)
Yes 0.69 (0.14)
Learning problems 0.04* 0.94
No 0.76 (0.17)
Yes 0.71 (0.13)
Hearing problems <0.01* 0.03*
No 0.75 (0.14)
Yes 0.64 (0.16)
Vision problems 0.03* 0.44
No 0.76 (0.14)
Yes 0.70 (0.16)
Base on the death to perfect health scale (0.00 – 1.00).
*p-value < 0.05.was the only significant factor accounted for a lowered
HRQoL score by multiple regression.
Figure 2 showed HUI2 and HUI3 in relation to in-
creasing number of chronic health conditions the indi-
viduals with DS experienced. Both HUI2 and HUI3HUI3
gression Two-sample t-test Multiple regression
Mean (SD) p p
0.02* 0.20
0.59 (0.26)
0.42 (0.28)
0.02* 0.28
0.58 (0.27)
0.42 (0.26)
<0.01* 0.50
0.65 (0.26)
0.47 (0.26)
0.01* 0.54
0.63 (0.26)
0.48 (0.27)
<0.01* 0.03*
0.59 (0.25)
0.39 (0.28)
<0.01* 0.35
0.62 (0.24)
0.47 (0.29)
Figure 2 Relationship between health-related quality of life and chronic health conditions. (a) Association between HRQoL score from
HUI2 and HUI3 and number of any health conditions. The HRQoL scores of both HUI2 and HUI3 were both significant as the number of health
conditions increase since the p-values for both HUI2 and HUI3 are less than 0.001. However only the HRQoL score of HUI3 was significantly different
in the presence of co-morbidities, p-value less than 0.05. (b) and (c) shows the association between HRQoL scores from HUI2 and HUI3 and the
number of physical or developmental-behavioral condition respectively. The HRQoL score of HUI2 and HUI3 were significantly different as
the number of developmental-behavioural conditions increase since there p-values were both less than 0.001.
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tive relationship where HRQoL scores decreased as the
number of health problems increased. The extent of de-
crease detected is more sensitive in HUI3 than HUI2. As-
sessments of HUI2 and HUI3 in relation to increasing
number of any of the 5 physical health problems or any of
the 5 developmental-behavioral problems individually are
represented in Figure 2b) and c). Worth to note, a greater
inverse dosage effect was observed on HRQoL deficit
as the number of developmental-behavioral conditions
increased as compared to physical health problems.
The negative linear relationship between number of
chronic conditions and HRQoL was found to be sig-
nificant (p < 0.001) for developmental-behavioural con-
ditions but not for physical health problems (p > 0.05)
in both HUI2 and HUI3 classification method.Discussion
The goal of this study was to develop and validate the
use of HUI-Ch in the Chinese population and to inves-
tigate the HRQoL of people with DS in Hong Kong.
We have described the process for translation of the
HUI2 and HUI3 questionnaire into traditional Chinese
and the validation process. HUInc has validated and
approved more than 35 other languages so far, includ-
ing languages such as German [42], Spanish [43] and
French [44]. The standard translation process recom-
mended by HUInc is a published guideline by Guille-
min et al. on translation and cultural adaptation of
HRQoL questionnaires [45]. Validation process was com-
pleted with direct oversight by HUI developers, and the
HUI-Ch received final approval from the developers of
HUI.
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system for measuring health status and HRQoL for a
broad range of subjects. The sample of our study covers
a broad age range, assessing the HRQoL of 109 people
with DS from age of 5 and above. As compared to find-
ings of local population health survey [36], we found a
much higher occurrence rates of physical health and
developmental-behavioral problems amongst DS sub-
jects in this study, signifying that the chronic health con-
ditions were more prevalent in DS. This study also
demonstrated that the HRQoL of people with DS is less
favorable than a reference group with no disability from
a general population cohort without any reports of
chronic illness [41]. When comparing to the HRQoL of
different conditions found in past studies that used
HUI, the HRQoL of subjects with DS in the current
study is found to be generally lower. This can be seen
in Table 3. Since the current study is the first HRQoL
study using HUI both in Chinese and in people with
DS, this makes it difficult to make direct comparison
with other relevant studies and we were only able to
compare with HRQoL of other patient groups in other
countries. After publication, we will conduct further
studies in local Chinese population in Hong Kong and
this will allow us to compare findings among popula-
tions with different medical conditions and further con-
firm the validity of HUI-Ch.
Further analysis relating HRQoL and chronic health
conditions found that none of the physical health issues
assessed suggested significant negative association with
HRQoL. In contrast, hearing and behavior problems were
found to significantly decrease the HRQoL of people with
DS, which is actually in line with the observations of many
local parents of DS children and the previous quality ofTable 3 Comparison of HUI3 scores in studies of different con
Current study
(n = 109)
Tilford et al.
2012 [46]
(n = 146)
Manuel et a
2002 [47]
(n = 8258)
Country study
conducted in
Hong Kong USA Canada
Gender F: 44% F: 15% F:63%
Age (Mean ± SD; Range) 23.6 y ± 8.5 (5–53) 8.6 y ± 3.3 (4–17) Not reported
Condition studied Down syndrome Autistic spectrum
disorder
Musculoskele
HUI3 score
Overall 0.55 ± 0.27 0.66 ± 0.23
Chronic orthopaedic 0.47 ± 0.23
(n = 11)
0.87
Hearing 0.39 ± 0.28
(n = 21)
Vision 0.47 ± 0.29
(n = 50)life studies on subjects with hearing impairment [52,53]
and with behavioral problems [22]. In spite of the existing
evidence linking developmental disabilities and impaired
quality of life [22], there are so far lacking evidence on its
impact on DS subjects. Our findings help to bridge this
knowledge gap.
Additionally, a gradient relationship was observed, with
increasing number of developmental-behavioral problems
resulted in more deficit of HRQoL. This is an important
finding on DS subjects which were not reported previ-
ously. Developmental issues such as sensory impairments
(hearing, vision) may impair individual subject’s ability
to communicate, consequently provoking frustration and
problem behaviors, as they are unable to express them-
selves. Thus, each additional developmental-behavioral
problem would escalate the burden to individual subject
with DS and reduce their quality of life. In addition, deteri-
orations in health may also be associated with an increase
in aggressive behavior, particularly when there were com-
munication difficulties in expressing underlying medical
problems, as shown in previous studies on those with in-
tellectual disabilities [54,55]. Thus, behavior problems
could possibly be an indication for some undiagnosed ill-
ness, reflective by a lowered HRQoL.
Effective surveillance and appropriate interventions to-
wards hearing impairment, behavioral problems and
other relevant developmental-behavioral problems would
certainly help to improve the quality of life of DS subjects.
Currently, there are no health surveillance programs
for adults with DS to assess their hearing or behavior
problems. Health care professionals looking after subjects
with DS should be alerted to look for these potential
developmental-behavioral problems to minimize its ad-
verse impact. Meanwhile, regular surveillance programditions
l. Petrou et al.
2007 [48]
(n = 120)
Smith-Olinde et al.
2008 [49] (n = 103)
Quinn et al.
2004 [50]
(n = 243)
Boulton et al.
2006 [51]
(n = 79)
UK USA USA UK
F: 45% F: 49% F: 52% F: 41%
7.9 y (5–12) 7.3 y ± 1.9 (5–10) 10 y 6.2 y ± 1.5 (3–8)
tal Hearing
impairment
Hearing loss Retinopathy of
prematurity
vision impairment
or blindness
0.63 ± 0.32 0.62 ± 0.20
0.59 ± 0.39 0.34 ± 0.43
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for people with DS.
Furthermore, the ability to quantify HRQoL has broad
implications. It would be useful for healthcare profes-
sionals, social workers, and counselors to communicate
to expectant parents about the realistic outcome of car-
ing for someone with DS.
Various limiting factors warrant consideration. 1) For
the study population, surveys were administered through
HKDSA events, classes, and gatherings; therefore, the
group of individuals with DS who are severely disabled
or require intensive medical monitoring might not be in-
cluded. This may result in surveying the healthier popula-
tion, thus underestimating the self-reported health condition
occurrence rate. 2) The survey was proxy-assessed by par-
ents/caregivers and arguments regarding the reliability of
proxy-results have been queried. However, it has been sug-
gested that agreement and reliability tend to be valid if the
survey was completed by close relatives [56], which in our
case all respondents were parents or caregivers. 3) As a gen-
eric instrument, HUI was used in this study to assess the
HRQoL of people with DS; concrete information on quality
of life specifically related to DS may not have been included.
To the best of our knowledge, this is the first study
which assessed and quantified the HRQoL of Chinese
people with DS. The valuable dataset allows healthcare
professionals, counselors, social workers, and caregivers to
be alerted about the adverse impact of developmental-
behavioral problems on the overall HRQoL of people with
DS. In addition, quantifiable measure of HRQoL would
also facilitate longitudinal study on well-being of DS sub-
jects and evaluation of effectiveness of intervention pro-
grams in the near future.
Conclusions
This study validated the HUI-Ch and was applied on
people with DS in Hong Kong, which concluded with
valuable information on the HRQoL and in relation to
the chronic health problems incurred.
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Additional file 1: Table S1. HUI2 Multi-Attribute Health Status Classification
System.
Additional file 2: Table S2. HUI3 Multi-Attribute Health Status Classification
System.
Additional file 3: Table S3. Description of Assigned Ranges of Overall
HUI2 and HUI3 Scores to Categories of Disability: None; Mild; Moderate;
and Severe.
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